Accueil / Tag Archives: Personnel

Tag Archives: Personnel

Algiax Pharmaceuticals appoints Prof. Claudia Sommer and Dr. Klaus-Dieter Langner to join its Scientific Advisory Board

Friday, July 19th 2019 at 5:00am UTC Clinical neuropathic pain expert Prof. Sommer and long-time pain pharma industry expert Dr. Langner to consult Algiax Pharmaceuticals in the development of AP-325 and further assetts. DÜSSELDORF, Germany–(BUSINESS WIRE)– Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for …

Plus »

Lysogene Establishes Scientific Advisory Board with International Experts in CNS Gene Therapy

Thursday, July 18th 2019 at 4:00pm UTC PARIS–(BUSINESS WIRE)– Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, Phase 3, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of world-leading experts in gene therapy …

Plus »

OncoCell MDx Appoints Renowned Urologic Pathologist as Chief Medical Officer

Thursday, July 18th 2019 at 12:45pm UTC ROYAL OAK, Mich.–(BUSINESS WIRE)– OncoCell MDx, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced that Kirk Wojno, M.D., has joined the company’s leadership team as its Chief Medical Officer. Dr. Wojno, a renowned urologic pathologist …

Plus »

Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors

Wednesday, July 17th 2019 at 12:00pm UTC – Nolet will serve as Chair of the Audit Committee – NEWARK, Calif.–(BUSINESS WIRE)– ?Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing a new category of high-performance neuromodulators for use in treating aesthetic and therapeutic conditions, today announced the appointment of Chris …

Plus »

Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer

Wednesday, July 17th 2019 at 1:00pm UTC Company Builds Leadership Team for Next Stage of Growth; Promotes Jo Viney, PhD, to President and Chief Scientific Officer and Appoints Vikas Goyal as Senior Vice President of Business Development CAMBRIDGE, Mass.–(BUSINESS WIRE)– Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics …

Plus »

Seer Announces Appointment of Mark McClellan, MD, PhD to Board of Directors

Wednesday, July 17th 2019 at 1:01pm UTC -Completes additional $17.5 million financing round- -Advancing pipeline of first-in-class liquid biopsy products for early, pre-symptomatic detection of cancer and neurological diseases- -Recent platform advancements in speed, cost and protein coverage accelerating vision to provide proteomic information at scale- SOUTH SAN FRANCISCO, Calif.–(BUSINESS …

Plus »

Relay Therapeutics Names Doug Ingram and Deep Nishar to Its Board of Directors

Wednesday, July 17th 2019 at 11:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced the appointment of Douglas S. Ingram and Deep Nishar to its board of directors. “Relay Therapeutics has made significant advances in integrating unprecedented computational …

Plus »

Aurinia Announces Further Strengthening of the Senior Management Team

Thursday, July 18th 2019 at 10:30am UTC – Max Donley appointed EVP, Internal Operations and Strategy – – Glenn Schulman appointed SVP, Corporate Communications and Investor Relations – VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX: AUP) (the “Company”), a late-stage clinical biopharmaceutical company with ongoing research in lupus …

Plus »

Gilead Sciences Announces Changes to Senior Leadership Team

Wednesday, July 17th 2019 at 12:30pm UTC FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) announced today changes to the company’s senior leadership team. Gregg Alton, Chief Patient Officer, and Katie Watson, Executive Vice President, Human Resources, will be departing Gilead. Jyoti Mehra has been named Executive Vice President, …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.